These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25024919)

  • 1. Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors.
    Lai PS; Wong YY; Low YC; Lau HL; Chin KF; Mahadeva S
    PeerJ; 2014; 2():e451. PubMed ID: 25024919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
    Craig DG; Thimappa R; Anand V; Sebastian S
    QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.
    Yachimski PS; Farrell EA; Hunt DP; Reid AE
    Arch Intern Med; 2010 May; 170(9):779-83. PubMed ID: 20458085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study.
    Abukhalil AD; Ali O; Saad A; Falana H; Al-Shami N; Naseef HA; Rabba A
    Int J Gen Med; 2023; 16():141-150. PubMed ID: 36659914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate Prescription of Proton Pump Inhibitors in a Community Setting.
    Nguyen PV; Tamaz R
    Can J Hosp Pharm; 2018; 71(4):267-271. PubMed ID: 30186000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department.
    Zhang Y; Yang H; Kong J; Liu L; Ran L; Zhang X; Yun J; Gu Q
    J Clin Pharm Ther; 2021 Feb; 46(1):149-157. PubMed ID: 33015848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria.
    Okoro RN; Abdullahi K; Dayar DA
    Med Access Point Care; 2021; 5():23992026211062729. PubMed ID: 36204491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
    Soubra L; Issa M
    Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting.
    Atkins R; Smith L
    Consult Pharm; 2013 Dec; 28(12):786-92. PubMed ID: 24322962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous proton-pump inhibitors in a teaching hospital practice.
    Hoover JG; Schumaker AL; Franklin KJ
    Dig Dis Sci; 2009 Sep; 54(9):1947-52. PubMed ID: 19034652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors: Are we still prescribing them without valid indications?
    Akram F; Huang Y; Lim V; Huggan PJ; Merchant RA
    Australas Med J; 2014; 7(11):465-70. PubMed ID: 25550719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.
    Kelly OB; Dillane C; Patchett SE; Harewood GC; Murray FE
    Dig Dis Sci; 2015 Aug; 60(8):2280-6. PubMed ID: 25840918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit of PPI Prescribing Practices: A Risk to Patient Safety?
    O’Connell L; O’Connell RM; Ahmed O; Mealy K
    Ir Med J; 2019 Apr; 112(4):911. PubMed ID: 31241278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit.
    Joret-Descout P; Dauger S; Bellaiche M; Bourdon O; Prot-Labarthe S
    Int J Clin Pharm; 2017 Feb; 39(1):181-186. PubMed ID: 28093644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pattern of Intravenous Proton-Pump Inhibitor Utilization at an Academic Medical Center in Riyadh, Saudi Arabia.
    Mohzari YA; Alsaegh A; Basheeruddin Asdaq SM; Al Shanawani SN; Albraiki AA; Bagalb A
    J Res Pharm Pract; 2020; 9(3):151-154. PubMed ID: 33489984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.
    Liu L; Yu Y; Fan Q; Wu Z; Li X; Luo H
    BMC Health Serv Res; 2022 Mar; 22(1):417. PubMed ID: 35351121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of inappropriate utilization of intravenous proton pump inhibitors.
    Afif W; Alsulaiman R; Martel M; Barkun AN
    Aliment Pharmacol Ther; 2007 Mar; 25(5):609-15. PubMed ID: 17305762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.